
Afadel 30 Tablet
Marketer
Adley Formulations
Salt Composition
Afatinib dimaleate (30mg)
Overview Afadel 30 Tablet
Afadel 30mg tablets are indicated for treating non-small cell lung cancer in adults with specific epidermal growth factor receptor (EGFR) gene mutations. Optimal absorption requires administration on an empty stomach, consistently at the same time daily. Dosage and frequency are determined by your physician based on your individual needs and may be adjusted. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be apparent immediately; continued use is essential unless otherwise directed by your doctor. Common side effects include nausea, diarrhea, rash, and dry skin. Severe diarrhea requires prompt medical attention, including appropriate medication and hydration. Regular blood tests may be necessary. Photosensitivity is possible; sunscreen and protective clothing are recommended during sun exposure. Report any eye discomfort, such as redness, dryness, or pain. Prior to commencing treatment, disclose any pre-existing respiratory, hepatic, or renal conditions, and all current medications, particularly anti-infectives, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; women of childbearing age must employ effective contraception throughout treatment.
Uses of Afadel 30 Tablet
Lung cancer (excluding small cell type)
Major Benefits of Afadel 30 Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Afadel 30 Tablet should be administered on an empty stomach.
Common Side effects of Afadel 30 Tablet:
- Diarrhea
- Rash
- Dry skin
- Nausea
- Vomiting
- Loss of appetite
- Itching
- Stomatitis (Inflammation of the mouth)
- Nail disorder
How to use Afadel 30 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Afadel 30 Tablet should be administered on an empty stomach.
How Afadel 30 Tablet works:
Afadel 30 Tablet is an anticancer drug that targets and blocks the EGFR, HER2, and HER4 enzyme receptors crucial for cancer cell proliferation. This inhibition disrupts the cellular signaling pathways that drive tumor growth, thus hindering or slowing cancer progression.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Afadel 30 Tablet and alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Using Afadel 30 Tablet during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in exceptional, life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Use of Afadel 30 Tablet while breastfeeding is likely inadvisable. Preliminary evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Driving ability while using Afadel 30 Tablet is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Afadel 30 Tablet appears to pose minimal risk for individuals with kidney impairment. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Afadel 30 Tablet appears safe for individuals with liver conditions. Preliminary evidence indicates dose modification may not be necessary. However, physician consultation is recommended.
What if you forget to take Afadel 30 Tablet :
Omit any missed Afadel 30 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Afadel 30 Tablet
| Label | Value |
|---|---|
| Chemical Category | Quinazoline-Butenamide Hybrid |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Tyrosine kinase inhibitor drugs |
